Gonadal tumor risk in pediatric and adolescent phenotypic females with disorders of sex development and Y chromosomal constitution with different genetic etiologies

Objectives This retrospective study sought to investigate the risk and proportion of gonadal neoplasms in phenotypic female pediatric patients with DSD and the presence of the Y chromosome and different genetic backgrounds in a single Chinese center. Materials and Methods From January 2012 to December 2020, pediatric and adolescent patients with DSD and the presence of the Y chromosome who had unambiguous female genitalia and underwent bilateral gonadectomy or gonadal biopsy were included in this study. Patients’ demographics, karyotype, laboratory test results, gross pathology, and histology of gonadal tissue were all collected. The patients were divided into three groups based on their different genetic backgrounds, and the percentage of gonadal tumors was calculated to assess the risk of gonadal tumor and malignancy by etiology. Results A total of 22 patients with DSD and an unambiguous female phenotype with a Y chromosome were recruited. The mean age was 10.91 ± 4.99 years (9 months to 19 years). Gonadal neoplasia was confirmed in six (27.3%) cases by pathological examination of surgical gonadal tissue samples. Among 44 gonadal samples from these 22 patients, the following were identified: five gonadoblastomas, three dysgerminomas, and two Leydig cell tumors. The youngest patient with a tumor was a 2-year-old girl with 46,XY complete gonadal dysgenesis (46,XY CGD or Swyer syndrome) and bilateral gonadoblastoma. Patients with 46,XY complete gonadal dysgenesis (4/6; 66.7%) had the highest tumor occurrence rate. Among 10 patients with Turner syndrome with the presence of the Y chromosome, only one patient was diagnosed with a gonadal tumor. Leydig cell tumor was diagnosed in only one of six patients with 46,XY androgen synthesis/action disorders. Conclusion Pediatric patients with 46,XY complete gonadal dysgenesis had a significantly increased risk of developing gonadal tumors and underwent prophylactic gonadectomy as soon as the diagnosis was confirmed, whereas those with Turner syndrome with Y chromosome and 46,XY androgen synthesis/action disorders had a relatively low risk. In view of the limited number of patients, a large multicenter study with close follow-ups is needed to support these conclusions.

[1]  A. Kunwar,et al.  17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature , 2022, Journal of the Endocrine Society.

[2]  Y. Chen,et al.  [Clinical characteristics and CYP17A1 gene mutation analysis in patients with 17α-hydroxylase/17, 20-lyase deficiency and testicular tumor]. , 2021, Zhonghua nei ke za zhi.

[3]  M. Nie,et al.  Mutation of c.244G>T in NR5A1 gene causing 46, XY DSD by affecting RNA splicing , 2021, Orphanet Journal of Rare Diseases.

[4]  ISCN 2020 , 2020 .

[5]  D. Orbach,et al.  Disorder of sex development with germ cell tumors: Which is uncovered first? , 2020, Pediatric blood & cancer.

[6]  G. Bollinger,et al.  Population Study , 2020, Definitions.

[7]  W. Brickman,et al.  Turner Syndrome with Y chromosome: Spontaneous Thelarche, Menarche and Risk of Malignancy. , 2020, Journal of pediatric and adolescent gynecology.

[8]  C. Bokemeyer,et al.  Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Rodríguez-Galindo,et al.  Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study , 2018, Pediatric blood & cancer.

[10]  Yunli Bi,et al.  Efficacy and safety of percutaneous administration of dihydrotestosterone in children of different genetic backgrounds with micropenis , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[11]  G. Conway,et al.  Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy , 2017, Clinical endocrinology.

[12]  K. Nathanson,et al.  A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[13]  Q. Tian,et al.  Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y‐derived sequence , 2017, Clinical endocrinology.

[14]  L. Looijenga,et al.  Gonadal dysgenesis in disorders of sex development: Diagnosis and surgical management. , 2016, Journal of pediatric urology.

[15]  S. Lynch,et al.  Gonadoblastoma in patients with 45,X/46,XY mosaicism: A 16-year experience. , 2016, Journal of pediatric urology.

[16]  T. Kolon,et al.  Malignancy in disorders of sex development , 2016, Translational andrology and urology.

[17]  L. Liang,et al.  [Clinical and genetic analysis of an infant with isolated 17, 20-lyase deficiency]. , 2016, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[18]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[19]  Y. Deng,et al.  Gonadal malignancy in 202 female patients with disorders of sex development containing Y-chromosome material , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[20]  M. Berberoğlu,et al.  Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[21]  L. Looijenga,et al.  Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. , 2015, European urology.

[22]  Dan Zhang,et al.  Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences. , 2014, Human reproduction.

[23]  S. Ida,et al.  Tumors of Bilateral Streak Gonads in Patients with Disorders of Sex Development Containing Y Chromosome Material , 2014, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[24]  V. Sutton,et al.  State of the art review in gonadal dysgenesis: challenges in diagnosis and management , 2014, International Journal of Pediatric Endocrinology.

[25]  L. Wünsch,et al.  Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis , 2012, BJU international.

[26]  A. Sinclair,et al.  SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype , 2012, BMC Medical Genetics.

[27]  L. Looijenga,et al.  A 46,XY Female DSD Patient with Bilateral Gonadoblastoma, a Novel SRY Missense Mutation Combined with a WT1 KTS Splice-Site Mutation , 2012, PloS one.

[28]  T. Ulbright,et al.  Difficult differential diagnoses in testicular pathology. , 2012, Archives of pathology & laboratory medicine.

[29]  A. Swerdlow,et al.  Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. , 2008, The Lancet. Oncology.

[30]  Svend Juul,et al.  Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[31]  S. Ahmed,et al.  Consensus Statement on Management of Intersex Disorders , 2006, Pediatrics.

[32]  L. Looijenga,et al.  Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. , 2006, The Journal of clinical endocrinology and metabolism.

[33]  Yun-Fai Chris Lau,et al.  TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells , 2006, BMC Cancer.

[34]  P. A. Lee,et al.  Consensus statement on management of intersex disorders , 2006, Archives of Disease in Childhood.

[35]  L. Horn,et al.  Histologic Analysis of Gonadal Tissue in Patients With Ullrich-Turner Syndrome and Derivative Y Chromosomes , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[36]  G. Queipo,et al.  Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants , 2005, Modern Pathology.

[37]  C. Bouvattier,et al.  Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. , 2002, The Journal of clinical endocrinology and metabolism.

[38]  K. Choy,et al.  Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17 alpha-hydroxylase deficiency. , 2001, Molecular genetics and metabolism.

[39]  C. Gravholt,et al.  Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. , 2000, The Journal of clinical endocrinology and metabolism.

[40]  M. Forest,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society 17�-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation* , 2022 .

[41]  B. Ure,et al.  Gonadal histology with testicular carcinoma in situ in a 15-year-old 46,XY female patient with a premature termination in the steroidogenic acute regulatory protein causing congenital lipoid adrenal hyperplasia. , 1999, The Journal of clinical endocrinology and metabolism.

[42]  SY. Tan,et al.  Risk of gonadoblastoma in female patients with Y chromosome abnormalities and dysgenetic gonads , 1999, Journal of paediatrics and child health.

[43]  J. Olsen,et al.  Occurrence of cancer in women with Turner syndrome. , 1996, British Journal of Cancer.

[44]  D. Lowe,et al.  GONADAL NEOPLASIA AND ABNORMAL SEXUAL DIFFERENTIATION , 1990, Clinical endocrinology.

[45]  C. Jackson,et al.  Gonadoblastoma in infancy: indications for early gonadectomy in 46XY gonadal dysgenesis. , 1988, Journal of pediatric surgery.